表紙:世界のがん免疫アッセイ市場予測
市場調査レポート
商品コード
911641

世界のがん免疫アッセイ市場予測

Immuno-Oncology Assay Market 2019-2025

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=137.14円
世界のがん免疫アッセイ市場予測
出版日: 2019年08月26日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは世界のがん免疫アッセイ市場について調査しており、市場機会、成長および阻害要因、技術・癌のタイプ・用途・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 レポートの概要

  • 調査方法およびツール
  • 市場分析

第2章 市場の概要および洞察

  • レポートの範囲
  • アナリストの洞察および現在の市場動向
  • 規則および規制

第3章 競合情勢

  • 企業シェア分析
  • 主要戦略分析
  • 主要企業分析
    • PerkinElmer, Inc.
    • Thermo Fisher Scientific Inc.
    • Agilent Technologies, Inc.
    • Illumina, Inc.
    • F. Hoffmann-La Roche Ltd.

第4章 市場の決定要因

  • 成長要因
  • 阻害要因
  • 市場機会

第5章 市場セグメント

  • 技術別
    • ポリメラーゼ連鎖反応(PCR)
    • 次世代シーケンシング(NGS)
    • 免疫学的検査
    • その他の技術(フローサイトメトリー)
  • 癌のタイプ別
    • 肺癌
    • 大腸癌
    • 黒色腫
    • 膀胱癌
    • その他
  • 用途別
    • 臨床診断
    • 研究

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • その他
  • その他の地域

第7章 企業プロファイル

  • Agilent Technologies, Inc.
  • Almac Group Ltd.
  • AstraZeneca PLC
  • Biodesix, Inc.
  • Bio-Rad Laboratories, Inc.
  • Charles River Laboratories International, Inc.
  • Crown Bioscience Inc.
  • F. Hoffmann-La Roche Ltd
  • Foundation Medicine, Inc.
  • Horizon Discovery Group PLC
  • HTG Molecular Diagnostics, Inc.
  • Illumina, Inc.
  • InSphero AG
  • Lunaphore Technologies S.A.
  • Merk KGaA
  • NANOBIOTEC, LLC
  • NanoString Technologies, Inc
  • Perkinelmer, Inc.
  • Qiagen NV
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
図表

List of Tables

  • 1. GLOBAL IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 2. GLOBAL PCR IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL NGS IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL IMMUNOASSAYS IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL OTHER TECHNOLOGIES IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2018-2025 ($ MILLION)
  • 7. GLOBAL IMMUNO-ONCOLOGY ASSAY FOR LUNG CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 8. GLOBAL IMMUNO-ONCOLOGY ASSAY FOR COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. GLOBAL IMMUNO-ONCOLOGY ASSAY FOR MELANOMA MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 10. GLOBAL IMMUNO-ONCOLOGY ASSAY FOR BLADDER CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 11. GLOBAL IMMUNO-ONCOLOGY ASSAY FOR OTHER CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 12. GLOBAL IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 13. GLOBAL IMMUNO-ONCOLOGY ASSAY IN CLINICAL DIAGNOSTIC APPLICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 14. GLOBAL IMMUNO-ONCOLOGY ASSAY IN RESEARCH APPLICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 15. GLOBAL IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 16. NORTH AMERICAN IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 17. NORTH AMERICAN IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 18. NORTH AMERICAN IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2018-2025 ($ MILLION)
  • 19. NORTH AMERICAN IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 20. EUROPEAN IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 21. EUROPEAN IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 22. EUROPEAN IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2018-2025 ($ MILLION)
  • 23. EUROPEAN IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 24. ASIA-PACIFIC IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 25. ASIA-PACIFIC IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 26. ASIA-PACIFIC IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2018-2025 ($ MILLION)
  • 27. ASIA-PACIFIC IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 28. REST OF THE WORLD IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 29. REST OF THE WORLD IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2018-2025 ($ MILLION)
  • 30. REST OF THE WORLD IMMUNO-ONCOLOGY ASSAY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

List of Figures

  • 1. GLOBAL IMMUNO-ONCOLOGY ASSAY MARKET SHARE BY TECHNOLOGY, 2018 VS 2025 (%)
  • 2. GLOBAL IMMUNO-ONCOLOGY ASSAY MARKET SHARE BY CANCER TYPE, 2018 VS 2025 (%)
  • 3. GLOBAL IMMUNO-ONCOLOGY ASSAY MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
  • 4. GLOBAL IMMUNO-ONCOLOGY ASSAY MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 5. US IMMUNO-ONCOLOGY ASSAY MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. CANADA IMMUNO-ONCOLOGY ASSAY MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. UK IMMUNO-ONCOLOGY ASSAY MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. FRANCE IMMUNO-ONCOLOGY ASSAY MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. GERMANY IMMUNO-ONCOLOGY ASSAY MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. ITALY IMMUNO-ONCOLOGY ASSAY MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. SPAIN IMMUNO-ONCOLOGY ASSAY MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. ROE IMMUNO-ONCOLOGY ASSAY MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. INDIA IMMUNO-ONCOLOGY ASSAY MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. CHINA IMMUNO-ONCOLOGY ASSAY MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. JAPAN IMMUNO-ONCOLOGY ASSAY MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF ASIA-PACIFIC IMMUNO-ONCOLOGY ASSAY MARKET SIZE, 2018-2025 ($ MILLION)
  • 17. REST OF THE WORLD IMMUNO-ONCOLOGY ASSAY MARKET SIZE, 2018-2025 ($ MILLION)
目次
Product Code: OMR2019859

Title:
Global Immuno-Oncology Assay
Market Size, Share & Trends Analysis Report by Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Immunoassays, and Other Technologies), by Cancer Type (Lung Cancer, Colorectal Cancer, Melanoma, Bladder Cancer, and Others), by Application (Clinical Diagnostic and Research) and Forecast 2019 - 2025.

The global immuno-oncology assay market is expected to grow significantly over the forecast period (2019 - 2025). The study and development of treatments that leverages the immune system of the body for fighting against the cancer are termed as immuno-oncology. Major factors that are augmenting the market growth of the market includes increasing incidence and prevalence rate of cancer and rising adoption of targeted therapy. Further, technological advancement in molecular diagnostics, extensive R&D in cancer diagnostics, and increasing clinical trials in immunotherapy are further expected to contribute to the market growth over the forecast period. The global immuno-oncology assay market is segmented on the basis of technology, cancer type, application, and region.

Geographically, the global immuno-oncology assay market is segmented into North America, Europe, Asia-Pacific, and Rest of the Word. Among these, North America held a dominant position in the global immuno-oncology assay market in 2018. North America has a well-developed healthcare system coupled with the cohesive government policies that contributes to its growth. In addition, the presence of major players such as Thermo Fisher Scientific Inc., Illumina Inc., and PerkinElmer Inc., in the region further support the market growth in the North American region. Moreover, Asia-Pacific market of immuno-oncology is estimated to exhibit considerable growth in the global immuno-oncology assay market owing to the major contribution from the emerging economies such as China and Japan. Rapidly developing healthcare infrastructure and rising medical tourism are some other factors that are propelling the market growth in the region.

In addition, the global immuno-oncology assay market has been influenced by the presence of several market players. These players adopt various strategies such as merger and acquisition, partnership, collaboration, product launch, and geographical expansion in order to stay competitive in the market. Some of the key market players include PerkinElmer, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Illumina, Inc., and F. Hoffmann-La Roche Ltd. For instance, in September 2018, F. Hoffmann La Roche Ltd. completed the acquisition of Tusk Therapeutics, immuno-oncology treatments developer, for up to $759 million. With this acquisition, the company successfully expanded its oncology pipeline that helped the company to strengthen its revenue stream.

Research Methodology

The market study of the global immuno-oncology assay market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Authenticate databases such as the National Institute of Health, WHO, and others
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalog
  • Annual reports and forward-looking statements of key players

The report is intended for market research firms, investment companies, pharmaceutical & biopharmaceutical companies, potential start-ups, venture capitalists, research institutes for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market delivering insights into the market for better business decisions.

Market Segmentation

  • 1. Global Immuno-Oncology Assay Market Research and Analysis by Technology
  • 2. Global Immuno-Oncology Assay Market Research and Analysis by Cancer Type
  • 3. Global Immuno-Oncology Assay Market Research and Analysis by End-User

The Report Covers:

  • Comprehensive research methodology of the global immuno-oncology assay market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global immuno-oncology assay market.
  • Insights about market determinants which are stimulating the global immuno-oncology assay market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. PerkinElmer, Inc.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. Swot Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Thermo Fisher Scientific Inc.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. Swot Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Agilent Technologies, Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. Swot Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Illumina, Inc.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. Swot Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. F. Hoffmann-La Roche Ltd.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. Swot Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Immuno-Oncology Assay Market by Technology
    • 5.1.1. Polymerase Chain Reaction (PCR)
    • 5.1.2. Next-Generation Sequencing (NGS)
    • 5.1.3. Immunoassays
    • 5.1.4. Other Technologies (Flow Cytometry)
  • 5.2. Global Immuno-Oncology Assay Market by Cancer Type
    • 5.2.1. Lung Cancer
    • 5.2.2. Colorectal Cancer
    • 5.2.3. Melanoma
    • 5.2.4. Bladder Cancer
    • 5.2.5. Others
  • 5.3. Global Immuno-Oncology Assay Market by Application
    • 5.3.1. Clinical Diagnostic
    • 5.3.2. Research

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Agilent Technologies, Inc.
  • 7.2. Almac Group Ltd.
  • 7.3. AstraZeneca PLC
  • 7.4. Biodesix, Inc.
  • 7.5. Bio-Rad Laboratories, Inc.
  • 7.6. Charles River Laboratories International, Inc.
  • 7.7. Crown Bioscience Inc.
  • 7.8. F. Hoffmann-La Roche Ltd
  • 7.9. Foundation Medicine, Inc.
  • 7.10. Horizon Discovery Group PLC
  • 7.11. HTG Molecular Diagnostics, Inc.
  • 7.12. Illumina, Inc.
  • 7.13. InSphero AG
  • 7.14. Lunaphore Technologies S.A.
  • 7.15. Merk KGaA
  • 7.16. NANOBIOTEC, LLC
  • 7.17. NanoString Technologies, Inc
  • 7.18. Perkinelmer, Inc.
  • 7.19. Qiagen NV
  • 7.20. Sartorius AG
  • 7.21. Thermo Fisher Scientific Inc.